KLRA
Kailera Therapeutics, Inc. Common Stock
NASDAQ: KLRA · HEALTHCARE · BIOTECHNOLOGY
$21.11
-2.55% today
Updated 2026-06-02
Market cap
$2.45B
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-1.78
Dividend yield
—
52W range
$16 – $28
Volume
0.9M
Kailera Therapeutics, Inc. Common Stock (KLRA) Financial Forecast & Price Target 2030
Revenue-driven projection model with historical context.
Price target summary
Current price
$21.11
12-Month target
—
2030 Target
—
Intrinsic (DCF)
—
Financial forecast
| Metric | 2025 |
|---|---|
| Revenue | $0.0B |
| EPS | — |
CAGR applied: — (capped 20%) · P/E: 25.00x (capped 25x) · Margin: 0.00%
Methodology
CAGR-based projection model. Research-backed estimates are being generated — check back soon for analyst consensus and management guidance.